Fatty Liver

21 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Liver Diseases

Narrower: Non-alcoholic Fatty Liver Disease 16

Treatments and conditions

Fatty Liver
Treatment and conditionWhere it standsTrials
Atezolizumab for fatty liverPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Berberine ursodeoxycholate for non-alcoholic fatty liver diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Bevacizumab + atezolizumab for fatty liverPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
DR10624 Injection for non-alcoholic fatty liver diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
ECC0509 for non-alcoholic fatty liver diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ECC0509 + ECC4703 for non-alcoholic fatty liver diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ECC4703 for non-alcoholic fatty liver diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Efruxifermin for non-alcoholic fatty liver diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for non-alcoholic fatty liver diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver for fatty liverPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Food Security Screening & Referral Program for non-alcoholic fatty liver diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
HSK31679 for non-alcoholic fatty liver diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
HU6 for non-alcoholic fatty liver diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Obeticholic acid for fatty liverTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Pegargiminase for non-alcoholic fatty liver diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PolyPill for non-alcoholic fatty liver diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for non-alcoholic fatty liver diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
SNP-610 for non-alcoholic fatty liver diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Standard Soy Milk for non-alcoholic fatty liver diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Survodutide for non-alcoholic fatty liver diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Very-low calorie diet for fatty liverTrial registered, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.